Add Row 
Add 
A New Hope in Cancer Treatment: Carolina BioOncology Institute and BioCytics
In the heart of Huntersville, North Carolina, a medical practice is challenging the status quo in cancer treatment. Founded in 2005 by Dr. John Powderly, the Carolina BioOncology Institute (CBOI) stands as a beacon of hope for metastatic cancer patients seeking alternative pathways of care outside standard chemotherapy. Offering access to pioneering Phase 1 clinical trials, CBOI champions a philosophy of fighting spirit and resilience, reminding patients that they have the right to explore new possibilities.
Understanding Phase 1 Clinical Trials
What sets CBOI apart is its commitment to provide “first in human” trials of the latest immunotherapies and cellular treatments. Unlike traditional clinics that might offer standard oncology treatments, CBOI focuses solely on non-chemotherapy options aimed at identically tailoring solutions to individual patients. The dedicated team at CBOI, comprised of top experts in oncology, pharmacology, and clinical research, works tirelessly to ensure that patients receive the most cutting-edge treatments available.
A Personal Approach: The BioCytics Human Applications Lab
Adjacent to CBOI is the innovative BioCytics Human Applications Lab (BHAL), which operates under the same vision of personalized cancer care. Spearheaded by a team of PhD scientists and biomedical engineers, BHAL specializes in growing patients’ tumors in a controlled environment. This groundbreaking research is essential for understanding how one’s immune cells can be engineered to combat cancer effectively. The ultimate goal? To manufacture custom therapies that offer patients a glimmer of hope in their battle against cancer.
The Power of Participation in Trials
Statistics reveal a disheartening truth: although a vast majority of cancer patients express interest in participating in treatment trials, only 3-7% actually do. This gap suggests a significant lack of awareness about the options available. As Dr. Powderly emphasizes, spreading the word about CBOI’s mission is paramount. When patients are informed about clinical trial opportunities, they empower themselves to consider all available options, thereby contributing not just to their health but to the future of cancer research.
A Community Call to Action
For those who know someone battling metastatic cancer, sharing information about CBOI's innovative approach could be life-changing. Dr. Powderly’s message is clear: explore the possibilities of participating in clinical trials as a meaningful step in treatment. With over 2,000 new cancer drugs and therapies in the development pipeline, the road to cures may be closer than we think. It’s time to shine a light on these promising alternatives and foster connections within our communities, ensuring that everyone has access to the options they deserve.
Write A Comment